Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2020 - Volume 24, Number 4
View All Articles in Issue

Page(s):  319

Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, lorazepam, benzodiazepine, anxiety disorders, preoperative sedation, anxiolysis, anterograde amnesia, status epilepticus, sedative, schizophrenia, delirium, cancer chemotherapy-induced nausea and vomiting

Related Categories: FORMULATIONS, GASTROENTEROLOGY, MENTAL HEALTH, NEUROLOGY, SURGERY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
Jul/Aug 2020
Pg. 319

Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
Jul/Aug 2019
Pg. 317

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 161

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 420

Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester
, Zheng Bo, White Catherine A, Li Dawei
Jan/Feb 2011
Pg. 74-77

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
Jul/Aug 2018
Pg. 321

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Midazolam 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 162

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Trissel Lawrence A
, Xu Quanyun A
May/Jun 2005
Pg. 235-237

Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 342

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride
Riggs Robert M
, English Brett A, Webster Andrew A, McGuire J Michael, Riordan James M, Worthington Mary A
May/Jun 1999
Pg. 235-238

Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2005
Pg. 472

Return to Top